UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-10, Vol.30 (10), p.1558-1571

2019

Volltextzugriff (PDF)

Ocular toxicities of MEK inhibitors and other targeted therapies

Annals of oncology, 2016-06, Vol.27 (6), p.998-1005

2016

Volltextzugriff (PDF)

Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence

International journal of chronic obstructive pulmonary disease, 2021-01, Vol.16, p.113-124

2021

Volltextzugriff (PDF)

Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons

International journal of chronic obstructive pulmonary disease, 2020-07, Vol.15, p.1529-1543

2020

Volltextzugriff (PDF)

Soybean meal improves the physical quality of extruded fish feed

Animal feed science and technology, 2009-03, Vol.149 (1), p.149-161

2009

Volltextzugriff (PDF)

First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)

European journal of cancer (1990), 2016-12, Vol.69, p.S14-S15

2016

Volltextzugriff (PDF)

Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines

Regulatory toxicology and pharmacology, 2022-08, Vol.133, p.105225-105225, Article 105225

2022

Volltextzugriff (PDF)

Multikinase inhibitors in the treatment of thyroid cancer : specific role of lenvatinib

Biologics, 2014-01, Vol.8 (default), p.129-139

2014

Volltextzugriff (PDF)

EARLY AND SUSTAINED ASTHMA CONTROL OVER 24 WEEKS AFTER TEZEPELUMAB INITIATION: REAL-WORLD ASCENT STUDY

Annals of allergy, asthma, & immunology, 2024-11, Vol.133 (6), p.S52-S52

2024

Volltextzugriff (PDF)

Synthetic study on the angular triquinanes

Journal of the Serbian Chemical Society, 2023, Vol.88 (10), p.975-983

2023

Volltextzugriff (PDF)

LBA13 Dostarlimab + chemotherapy (CT) vs pembrolizumab + CT in metastatic non-squamous non-small cell lung cancer (NSCLC): Updated Asian subgroup analyses of the PERLA trial

Annals of oncology, 2023-11, Vol.34, p.S1662-S1663

2023

Volltextzugriff (PDF)

EP11.02-07 Dostarlimab + CT vs Pembrolizumab + CT in Metastatic Non-Squamous NSCLC: Asian Subgroup Analyses of the PERLA Trial

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S617

2023

Volltextzugriff (PDF)

P4.11E.28 Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S407-S408

2024

Volltextzugriff (PDF)

LBA64 Overall survival from a phase II randomised double-blind trial (PERLA) of dostarlimab (dostar) + chemotherapy (CT) vs pembrolizumab (pembro) + CT in metastatic non-squamous NSCLC

Annals of oncology, 2023-10, Vol.34, p.S1309-S1309

2023

Volltextzugriff (PDF)

Age of Salpingo-Oophorectomy and Risk of Peritoneal Carcinomatosis in Patients with a BRCA Mutation

Journal of molecular and genetic medicine, 2015, Vol.9 (4)

2015

Volltextzugriff (PDF)

Abstract P5-09-04: Impact of premenopausal RRSO on breast cancer risk in BRCA1/2 mutation carriers: Maximizing bias-reduction

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-09-04

2019

Volltextzugriff (PDF)

Abstract P2-05-19: Impact of TP53 functional mutation type on clinical outcomes of advanced breast cancer patients

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-19

2017

Volltextzugriff (PDF)

Change of natural history of hereditary diffuse gastric cancer after identification of a novel CDH1 mutation

Annals of oncology, 2017-09, Vol.28, p.v503

2017

Volltextzugriff (PDF)

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-10, Vol.30 (10), p.1558

2019

Volltextzugriff (PDF)

23 - First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)

European journal of cancer (1990), 2016-12, Vol.69, p.S14-S15

2016

Volltextzugriff (PDF)

Germline and somatic multi-gene sequencing in patients (pts) with advanced high grade serous ovarian cancer (HGSOC) and triple negative breast cancer (TNBC)

Annals of oncology, 2016-10, Vol.27, p.vi535-vi535

2016

Volltextzugriff (PDF)

Abstract P3-09-05: Clinical outcome of patients with advanced triple negative breast cancer with germline and somatic variants in homologous recombination gene

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-09-05

2017

Volltextzugriff (PDF)

1533P - Expression of Wilmśtumour Gene (WT1) is Associated with Survival in Malignant Pleural Mesothelioma: Retrospective Analysis in a Single Center Series

Annals of oncology, 2012-09, Vol.23, p.ix496-ix496

2012

Volltextzugriff (PDF)

Expression of Wilmśtumour Gene (WT1) is Associated with Survival in Malignant Pleural Mesothelioma: Retrospective Analysis in a Single Center Series

Annals of oncology, 2012-09, Vol.23, p.ix496

2012

Volltextzugriff (PDF)

An attemp to use a pulsed CO2 laser for decontamination of radioactive metal surfaces

Journal of the Serbian Chemical Society, 2000-01, Vol.65 (5-6), p.445-450

2000

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(58)
Reviews
(1)

Sprache

Englisch
(52)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Humans
(12)
Substance Abuse
(7)
Adolescent
(6)
Social Media
(6)
Female
(5)
Male
(5)
Adult
(4)
Electronic Nicotine Delivery Systems
(4)
Biological And Medical Sciences
(3)
Biology
(3)
Cancer
(3)
Life Sciences & Biomedicine - Other Topics
(3)
Nicotine
(3)
Oncology
(3)
Patients
(3)
Review
(3)
Social Networks
(3)
Substance Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ocular toxicities of MEK inhibitors and other targeted therapies

Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence

Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons

Soybean meal improves the physical quality of extruded fish feed

First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)

Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines

Multikinase inhibitors in the treatment of thyroid cancer : specific role of lenvatinib

EARLY AND SUSTAINED ASTHMA CONTROL OVER 24 WEEKS AFTER TEZEPELUMAB INITIATION: REAL-WORLD ASCENT STUDY

Synthetic study on the angular triquinanes

LBA13 Dostarlimab + chemotherapy (CT) vs pembrolizumab + CT in metastatic non-squamous non-small cell lung cancer (NSCLC): Updated Asian subgroup analyses of the PERLA trial

EP11.02-07 Dostarlimab + CT vs Pembrolizumab + CT in Metastatic Non-Squamous NSCLC: Asian Subgroup Analyses of the PERLA Trial

P4.11E.28 Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA

LBA64 Overall survival from a phase II randomised double-blind trial (PERLA) of dostarlimab (dostar) + chemotherapy (CT) vs pembrolizumab (pembro) + CT in metastatic non-squamous NSCLC

Age of Salpingo-Oophorectomy and Risk of Peritoneal Carcinomatosis in Patients with a BRCA Mutation

Abstract P5-09-04: Impact of premenopausal RRSO on breast cancer risk in BRCA1/2 mutation carriers: Maximizing bias-reduction

Abstract P2-05-19: Impact of TP53 functional mutation type on clinical outcomes of advanced breast cancer patients

Change of natural history of hereditary diffuse gastric cancer after identification of a novel CDH1 mutation

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

23 - First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)

Germline and somatic multi-gene sequencing in patients (pts) with advanced high grade serous ovarian cancer (HGSOC) and triple negative breast cancer (TNBC)

Abstract P3-09-05: Clinical outcome of patients with advanced triple negative breast cancer with germline and somatic variants in homologous recombination gene

1533P - Expression of Wilmśtumour Gene (WT1) is Associated with Survival in Malignant Pleural Mesothelioma: Retrospective Analysis in a Single Center Series

Expression of Wilmśtumour Gene (WT1) is Associated with Survival in Malignant Pleural Mesothelioma: Retrospective Analysis in a Single Center Series

An attemp to use a pulsed CO2 laser for decontamination of radioactive metal surfaces

Suchergebnisse filtern